Alentis Therapeutics
Switzerland - Allschwil
BiotechnologyFocus: Monoclonal Antibody
Alentis Therapeutics is a life sciences company focused on Monoclonal Antibody.
OncologyGastroenterologyNephrology
Open Jobs
0
Pipeline & Clinical Trials
ALE.F02
Advanced Liver FibrosisClinical Trials (1)
NCT05939947A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis
Phase 1Phase 1/2
Clinical Trials (1)
NCT07169734A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Phase 1/2ALE.C04
Head and Neck CancerClinical Trials (1)
NCT06054477Study of ALE.C04 in Patients With Head and Neck Cancer
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT06747585A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Phase 1/2Phase 2
Clinical Trials (1)
NCT06047171Rescue of Nephrons With ALE.F02 (RENAL-F02)
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 clinical trials